Blood glucose decreased: FDA reporting patterns
47,554 FDA FAERS reports mention Blood glucose decreased. 23,041 reports have a serious outcome flag.
Medicines named as suspect
- Insulin Lispro: 7,951 reports
- Exenatide: 6,092 reports
- Insulin Glargine: 5,984 reports
- Insulin Human: 3,796 reports
- Metformin: 1,972 reports
- Insulin Aspart: 1,946 reports
- Dulaglutide: 1,699 reports
- Semaglutide: 1,228 reports
- Insulin Degludec: 1,085 reports
- Tirzepatide: 1,074 reports
- Liraglutide: 1,027 reports
- Insulin Detemir: 820 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.